Second Look at Drug Patents Act of 2020
USA116th CongressS-4253| Senate
| Updated: 7/21/2020
Patty Murray
Democratic Senator
Washington
Cosponsors (1)
Health, Education, Labor, and Pensions Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Second Look at Drug Patents Act of 2020 This bill imposes additional patent reporting requirements on the manufacturers of certain drugs approved by the Federal Drug Administration.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health
Drug safety, medical device, and laboratory regulationGovernment information and archivesIntellectual propertyPrescription drugs
Second Look at Drug Patents Act of 2020
USA116th CongressS-4253| Senate
| Updated: 7/21/2020
Second Look at Drug Patents Act of 2020 This bill imposes additional patent reporting requirements on the manufacturers of certain drugs approved by the Federal Drug Administration.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Patty Murray
Democratic Senator
Washington
Cosponsors (1)
Health, Education, Labor, and Pensions Committee
Health
Related Bills
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug safety, medical device, and laboratory regulationGovernment information and archivesIntellectual propertyPrescription drugs